Manufacturing vaccines during covid-19 cmos/cdmos to the rescue
By: Bhalgat, Mahesh
.
Contributor(s): Manjunatha, Satish Kumar.
Publisher: Mumbai Indian Journal of Pharmaceutical Science 2021Edition: Vol.53(11), Nov.Description: 6-9p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Pharma timesSummary: The Healthcare sector was never in greater focus than in 2020. With
the pandemic continuing unabated, the world looked to Science and the
scientific community for deliverance. And Science did not disappoint.
In less than a year of the pandemic, thanks to concerted global efforts,
more than 150 vaccine candidates became available as a possible cure
for COVID-19.
While 2020 was all about discovering a vaccine, 2021 is going to be
about how to take the vaccines to market in the shortest possible time.
With more than 2.6 million deaths worldwide (figures as on 9 March, 2021)
and counting, the need for speed cannot underscored.
However, to decipher the manufacturing challenge, one needs to
understand what goes behind producing a vaccine — raw materials,
technology and a complex manufacturing process. And finally, how and why
Contract Manufacturing Organizations (CMOs)/ Contract Development and
Manufacturing Organizations (CDMOs) are better positioned to bridge the
gap between vaccine demand and supply, safely and at speed.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2022-0904 |
The Healthcare sector was never in greater focus than in 2020. With
the pandemic continuing unabated, the world looked to Science and the
scientific community for deliverance. And Science did not disappoint.
In less than a year of the pandemic, thanks to concerted global efforts,
more than 150 vaccine candidates became available as a possible cure
for COVID-19.
While 2020 was all about discovering a vaccine, 2021 is going to be
about how to take the vaccines to market in the shortest possible time.
With more than 2.6 million deaths worldwide (figures as on 9 March, 2021)
and counting, the need for speed cannot underscored.
However, to decipher the manufacturing challenge, one needs to
understand what goes behind producing a vaccine — raw materials,
technology and a complex manufacturing process. And finally, how and why
Contract Manufacturing Organizations (CMOs)/ Contract Development and
Manufacturing Organizations (CDMOs) are better positioned to bridge the
gap between vaccine demand and supply, safely and at speed.
Click on an image to view it in the image viewer
There are no comments for this item.